Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 51655-813

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 51655-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure of Ondansetron Hydrochloride shown as a two-dimensional molecular diagram depicting its ring systems, bonds, and attached functional groups.*
FDA Label Image

Label (51655 813 54 Rev A 06 21 Nhc)

Label (51655 813 54   Rev A 06 21 Nhc)
Label for Ondansetron Tablets, USP 8 mg by Northwind Health Company, LLC. It is a prescription oral film-coated tablet packaged with 15 tablets. The label includes storage instructions, dosage details, and a barcode, along with the NDC number 51655-813-54.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.